Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.
about
Factors associated with influenza vaccination coverage among the elderly in South Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV)Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12)Influenza vaccination coverage among high-risk groups in 11 European countries.Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional studyImproving seasonal and pandemic influenza vaccinesWillingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys.Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance?A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations.Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, Singapore.Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting[Guillain-Barré syndrome after exposure to influenza].Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010.[Analysis of vaccination data of patients aged 60 years and older from Bavaria and Thuringia].The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation studyImplementation of the Recommendation to Vaccinate Pregnant Women against Seasonal Influenza - Vaccination Rates and Acceptance.The quality of preventive health care delivered to adults: results from a cross-sectional study in Southern Italy.Influenza vaccination coverage in the 2004/05, 2005/06, and 2006/07 seasons: a secondary data analysis based on billing data of the German associations of statutory health insurance physicians.Effect of the conditional cash transfer program Oportunidades on vaccination coverage in older Mexican peopleReasons for and against receiving influenza vaccination in a working age population in Japan: a national cross-sectional study.Reasons for low influenza vaccination coverage: cross-sectional survey in Poland.Comparison of different risk perception measures in predicting seasonal influenza vaccination among healthy Chinese adults in Hong Kong: a prospective longitudinal study.Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in GermanyLow vaccination coverage among italian healthcare workers in 2013.Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.Influenza Vaccination Coverage and Its Associated Factors among North Korean Defectors Living in the Republic of KoreaSeasonal influenza vaccination knowledge, risk perception, health beliefs and vaccination behaviours of nurses.Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries.Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010-2012.The social benefits of private infectious disease-risk mitigationInfluenza Vaccination Coverage Rate according to the Pulmonary Function of Korean Adults Aged 40 Years and Over: Analysis of the Fifth Korean National Health and Nutrition Examination Survey.Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.Increasing influenza vaccination coverage in recommended population groups in Europe.Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.Overview of vaccination policies for the elderly in Western European countries.Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines.Development and testing of an instrument to assess nurses' knowledge, risk perception, health beliefs and behaviours related to influenza vaccination.Understanding influenza vaccination behaviors: a comprehensive sociocultural framework.
P2860
Q28365373-DDCD5A2A-6A2F-40CC-B6D3-CE2D0137A620Q28388311-A606B8BD-A91D-41DA-9954-331A958BB3BDQ30226483-EC3B2849-AD27-46D1-B11E-D7164C8CCA83Q30351936-21A20DEC-8374-4DD1-93A2-946F1726A7B8Q30377211-581439A0-09B2-4A65-B1C0-C40645B63EB1Q30380132-0CE85AB4-AA49-4A4E-B141-A5B200BF78CAQ30388559-C2FE003C-A25A-4EBC-A28C-C70890C56BDCQ30391173-774C9A8A-F6C7-4EE7-B672-8E928943031CQ30394173-8D4DFBFB-342E-4454-9721-3C78CE0B77AAQ30395224-CC0154C5-C9E7-4C92-AFD9-6C48E39F82F1Q30415924-59477AF4-CDF8-498E-8B08-CBB87B4020C6Q30422387-DDB1FBEE-923D-4BE7-AA4C-798ADA562FFAQ30976776-232A231D-4C4B-4C96-B4AE-3AAB53810436Q31148484-893131DA-8C35-455D-B2F2-FB1C596F21F8Q33606786-A6F27711-570F-4C4D-9239-EA5B88DFCF42Q33611064-58C9EF02-D0E1-4DB1-B57E-F5F9F4213A4FQ33776797-1C217DA6-43C4-4502-9663-604B60528CD9Q34802890-05B08AA4-0C6E-490C-B13A-2B0C3B7B4DB5Q34815626-5845DEE8-1B91-4506-A442-2B938D5A9F96Q34839693-9E6F8B05-21B5-4526-B33F-8DD05F72EEC5Q34872526-1D08DF4F-67A2-40B5-AE9A-4D5574BEAFF4Q35618994-91144D41-075F-4473-B85A-1942C51999F1Q35887517-9BC59F2C-08C4-402F-A02C-C784E7A634C3Q35887577-0BE26AAF-19EE-4EE8-AB08-BE225979DF22Q35952784-CA2A1354-E545-4779-86FC-80746BAC8143Q36007804-58EAAB17-983D-4849-B09B-D553CBBB9B62Q36119262-F73A5024-FCD7-42BC-A5BE-C1C684436EEFQ36148024-E674E413-A11B-48AB-A42A-279CE7157DD7Q36176859-EECF799F-6358-4107-91D8-5D107384E4F4Q36547229-D67CF762-ABA0-417A-B572-F56A202D1420Q36809642-C2B138EE-981A-4CB6-BA10-C295032FAD27Q36887912-8555803C-39AC-4AC9-8895-B7BE3E1F5714Q36887932-5B8451B8-B43D-4C1E-9637-021FB6621ED7Q37177201-C6ABF333-7ED8-425B-A0EB-4BB66A75ABF7Q37434523-E4E1FBD3-8A40-4D48-8A1B-BDCB99184041Q37478325-B30B4CC1-1245-4FC1-953F-364B522299D1Q37538372-FB48236E-FC0C-42A7-8F25-C5C5F2953530Q37780548-8E0E2660-7383-4C16-8B08-E6856F11F554Q38012790-C689EF02-F82D-4169-A5C1-A114ED9C49D1Q38168899-44899251-2C9F-4059-BCDE-D96CCAC4D4B4
P2860
Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Influenza vaccination coverage ...... over six consecutive seasons.
@ast
Influenza vaccination coverage ...... over six consecutive seasons.
@en
type
label
Influenza vaccination coverage ...... over six consecutive seasons.
@ast
Influenza vaccination coverage ...... over six consecutive seasons.
@en
prefLabel
Influenza vaccination coverage ...... over six consecutive seasons.
@ast
Influenza vaccination coverage ...... over six consecutive seasons.
@en
P2860
P356
P1433
P1476
Influenza vaccination coverage ...... s over six consecutive seasons
@en
P2093
Thomas D Szucs
P2860
P2888
P356
10.1186/1471-2458-8-272
P407
P577
2008-08-01T00:00:00Z
P5875
P6179
1008377113